Pelthos Therapeutics Inc. Total Liabilities
Pelthos Therapeutics Inc. (PTHS) had Total Liabilities of $138.86 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-13
- 2026-06-30: Liabilities $138.86M.
- 2026-03-31: Liabilities $126.11M; Liabilities as first filed $110.28M.
- 2025-12-31: Liabilities $91.52M.
- 2025-09-30: Liabilities $68.18M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $138.86M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $126.11M 10-Q/A · filed 2026-08-13 | $110.28M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $91.52M 10-Q/A · filed 2026-08-13 | |
| 2025-09-30 | $68.18M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.32M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $5.11M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $4.08M 10-K · filed 2026-03-19 | $4.08M 10-K · filed 2025-03-27 |
| 2024-09-30 | $3.57M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.79M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.90M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $6.54M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $3.76M 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |